Companies / California / Clearpoint Neuro

· rebuilt nightly from public records

Signal Sheet

Selling to Clearpoint Neuro? Who to reach and why now

Clearpoint Neuro is a listed biotechnology company in Solana Beach, California. It raised $17.9M in Nov 2025 and its filings name 11 officers. Everything below links to the record it came from.

Listed company · Biotechnology · California

For sellersWhy Clearpoint Neuro is worth a call this quarterBuy Window: watching
$17.9M

New budget

Equity raise reported to the SEC, Nov 2025.

Capital
Track Clearpoint Neuro with a free trial →Get the next signal the day it is filed or posted.
Sell to companies like this?

Select your targets, see why-now for every account

Pick the companies and territory you sell to and get dated, sourced reasons like these for each one, ranked by who is most likely to buy now. Your list stays yours.

Want this matched to what you sell? Get early access to Pursuit Plans →
Start your free trial →

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Nov 20, 2025Raised $17.9M in equity from 46 investorsCapitalSEC filing

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerJoseph M. BurnettSEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerDanilo D'AlessandroSEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerJeremy L. StigallSEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerMazin SabraSEC filing, Nov 2025Named officer in the filing; part of the buying group
Chief Technology OfficerR. John FletcherSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerLynnette C. FallonSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerPascal E. R. GirinSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerB. Kristine JohnsonSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerMatthew B. KleinSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerLinda M. LiauSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerTimothy T. RichardsSEC filing, Nov 2025Technology and tooling decisions
Showing 3 of 11Start a free trial to see all 11 →

Turn this page into pipeline

Lakewave does the research, the stitching and the first draft with AI, so you spend your time selling.

Lead Hunting

Watch Clearpoint Neuro for the next signal

Lakewave tracks raises, new leaders, hiring and filings across your accounts and territory, and tells you the day something changes.

Surge and Campaigns

Reach the right people, verified

Find the decision makers, get mailbox-verified addresses and an AI draft written for that account, which you review. Send from your own inbox with open and reply tracking and a follow-up sequence.

Pursuit Plans, early access

A plan built around what you sell

Which accounts to pursue, why now, who to reach and what to say, matched to your product and the buyers you sell to.

Turn Clearpoint Neuro into pipeline with a free trial →

Emails that land, not bounce

Every address Lakewave gives you is checked against Clearpoint Neuro's mail server before you see it. Guessed addresses bounce, and bounces are what push a sender's domain toward the spam folder, so one bad list can cost a rep weeks of deliverability. Lakewave shows how each address was confirmed and leaves out the ones it cannot verify.

Use it two ways. Look up the verified address you need for a call you are already planning. Or let Lakewave do the whole job: find the accounts with a reason to buy now, the right people and their addresses, and draft a first email for each person, so you are not stitching together data sources and research by hand.

Try it on Clearpoint Neuro with a free trial →

About Clearpoint Neuro

HeadquartersSolana Beach, California, per the filing address
Industry groupBiotechnology
OwnershipListed company
Raise history$17.9M (Nov 2025)
Lakewave Rising1 · 1 kinds of evidence · rank in California after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Iambic Therapeutics · 74Tempest Therapeutics · 60GT Biopharma · 37Dare Bioscience · 25Caspian Therapeutics · 20Moonwalk Biosciences · 19See all 6 with a free trial →

Questions people ask

Did Clearpoint Neuro raise funding in 2025?

Yes. Clearpoint Neuro reported a $17.9M equity raise to the SEC on Nov 20, 2025 with 46 investors.

Who runs Clearpoint Neuro?

The company's SEC filing, Nov 2025 names Joseph M. Burnett (Executive Officer) among its officers.

Where is Clearpoint Neuro headquartered?

Solana Beach, California, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Rank your targets

Every account you select comes back scored by what changed this month, with the source for each fact.

Verified emails

Named officers from filings and announcements, each with an address verified against the mailbox. No bounces, no guessed patterns, no scraped profiles.

AI-generated first draft

Lakewave writes a first email for each person, tailored to their role and company. You edit, approve and send it from your own mailbox.

Hear about the next one

A weekly note on what changed across your targets, so no account moves without you knowing.

Free trial · No credit card · Built from public records, refreshed nightly

Compiled from public records and refreshed nightly; last updated Nov 10, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.